Topical and intermittent application of parathyroid hormone recovers alveolar bone loss in rat experimental periodontitis

Journal of Periodontal Research

Volumn 46, Issue 6, 2011, Pages 655-662

  Tokunaga, K ^a   Seto, H ^a   Ohba, H ^a   Mihara, C ^a   Hama, H ^a   Horibe, M ^a   Yoneda, S ^a   Nagata, T ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Alveolar bone; Experimental periodontitis; Parathyroid hormone; Topical administration

Indexed keywords

ALKALINE PHOSPHATASE; PARATHYROID HORMONE;

ALVEOLAR BONE LOSS; ANIMAL; ARTICLE; BIOSYNTHESIS; BONE REGENERATION; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG ADMINISTRATION; DRUG EFFECT; FETUS; FISCHER 344 RAT; IMAGE PROCESSING; LIGATION; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; OSTEOBLAST; PERIODONTITIS; RADIOGRAPHY; RAT; SKULL; TOPICAL DRUG ADMINISTRATION; WISTAR RAT;

ADMINISTRATION, TOPICAL; ALKALINE PHOSPHATASE; ALVEOLAR BONE LOSS; ANIMALS; BONE REGENERATION; CELL DIFFERENTIATION; CELLS, CULTURED; DRUG ADMINISTRATION SCHEDULE; FETUS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIGATION; OSTEOBLASTS; PARATHYROID HORMONE; PERIODONTITIS; RATS; RATS, INBRED F344; RATS, WISTAR; SKULL; X-RAY MICROTOMOGRAPHY;

EID: 80054907899     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2011.01386.x     Document Type: Article

References (34)

1. Pihlstrom BL, Michalowicz BS. Periodontal diseases. Lancet 2005;366:1809-1820.
2. Bhatavadekar NB, Paquette DW. Long-term follow-up and tomographic assessment of an intrabony defect treated with enamel matrix derivative. J Periodontol 2008;79:1802-1808.
3. Kitamura M, Nakashima K, Kowashi Y et al. Periodontal tissue regeneration using fibroblast growth factor-2: randomized controoled phase II clinical trial. PLoS ONE 2008;3:e2611.
4. Zhang L, Takahashi HE, Inoue J et al. Effects of intermittent administration of low dose human PTH (1-34) on cancellous and cortical bone of lumber vertebral bodies in adult beagles. Bone 1997;21:501-506.
5. Bilezikian JP, Silverberg SJ, Shane E, Parisien M, Dempster DW. Characterization and evaluation of asymptomatic primary hyperparathyroidism. J Bone Miner Res 1991;6(suppl 1):585-589.
6. Aubin JE, Bellows CG, Turksen K, Liu F, Heersche JNM. Analysis of the osteoblast lineage and regulation of differentiation. In: Slavkin H, Price P, eds. Chemistry and Biology of Mineralized Tissues. Amsterdam: Elsevier Science Publishers, 1992:267-276.
7. Ishizuya T, Yokose S, Hori M et al. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteolastic cells. J Clin Invest 1997;99:2961-2970.
8. Bellows CG, Ishida H, Aubin E, Heersche JNM. Parathyroid hormone reversibly suppresses the differentiation of osteoprogenitor cells into functional osteoblasts. Endocrinology 1990;127:3111-3116.
9. Okimoto N, Tsurukami H, Okazaki Y et al. Effects of a weekly injection of human parathyroid hormone (1-34) and withdrawal on bone mass, strength, and turnover in mature ovariectomized rats. Bone 1998;22:523-531.
10. Fujita T, Inoue T, Moril H et al. Effect of an intermittent weekly dose of human parathyroid hormone (1-34) on osteoporosis: a randomized double-masked prospective study using three dose levels. Osteoporos Int 1999;9:296-306.
11. Neer R, Arnaud C, Zanchetta J et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;19:1434-1441.
12. Barros SP, Silva MAD, Somerman MJ, Nociti FH Jr. Parathyroid hormone protects periodontitis-associated bone loss. J Dent Res 2003;82:791-795.
13. Bellows CG, Aubin JE, Heersche JNM, Antosz ME. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 1986;38:143-154.
14. Nagata T, Kaho K, Nishikawa S, Shinohara H, Wakano Y, Ishida H. Effect of prostaglandin E2 on mineralization of bone nodules formed by fetal rat calvarial cells. Calcif Tissue Int 1994;55:451-457.
15. Lowry OH, Roberts NR, Wu ML, Hixson WS, Crawford EJ. The quantitative histochemistry of barain. J Biol Chem 1954;20:19-37.
16. Cho HM, Choi HJ, Sun HJ et al. Transgenic mice overexpressing secreted frizzled-related proteins (sFRP) 4 under the control of serum amyloid P promoter exhibit low bone mass but did not result in disturbed phophate homeostasis. Bone 2010;47:263-271.
17. Villanueva AR, Lundin KD. A versatile new mineralized bone stain for stimultaneous assessment of tetracycline and osteoid seams. Stain Technol 1989;64:129-138.
18. Ohishi K, Ishida H, Nagata T et al. Thyroid hormone suppresses the differentiation of osteoprogenitor cells to osteoblasts, but enhances functional activities of mature osteoblasts in cultured rat calvaria cells. J Cell Physiol 1994;161:544-552.
19. Kadono H, Kido J, Kataoka M, Yamauchi N, Nagata T. Inhibition of osteoblastic differentiation by lipopolysaccharide extract from Porphyromonas gingivalis. Infect Immun 1999;67:2841-2846.
20. Ikedo D, Ohishi K, Yamauchi N, Kataoka M, Kido J, Nagata T. Stimulatory effects of phenytoin on osteoblastic differentiation of fetal rat calvaria cells in culture. Bone 1999;25:653-660.
21. Seto H, Toba Y, Takada Y et al. Milk basic protein (MBP) increases alveolar bone formation in rat experimental periodontitis. J Periodont Res 2007;42:85-89.
22. Seto H, Ohba H, Tokunaga K, Hama H, Horibe M, Nagata T. Topical administration of simvastatin recovers alveolar bone loss in rats. J Periodont Res 2008;43:261-267.
23. Di Paola R, Marzocco S, Mazzon E et al. Effect of aminoguanidine in ligature-induced periodontitis in rats. J Dent Res 2004;83:343-348.
24. Bezerra MM, de Lima V, Alencar VB et al. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol 2000;71:1009-1014.
25. de Lima V, Bezerra MM, de Menezes Alencar VB et al. Effects of chlorpromazine on alveolar bone loss in experimental periodontal disease in rats. Eur J Oral Sci 2000;108:123-129.
26. Leaffer D, Sweeney M, Kellerman LA, Avnur Z, Krstenansky JL, Vickery BH. Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH (1-34). Endocrinology 1995;136:3624-3631.
27. Fermor B, Skerry TM. PTH/PTHrP receptor expression on osteoblasts and osteocytes but not resorbing bone surfaces in growing rats. J Bone Miner Res 1995;10:1935-1943.
28. Podbesek R, Edourard C. Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology 1983;112:1000-1006.
29. Nakajima A, Shimoji N, Shiomi K et al. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 2002;11:2038-2047.
30. Seebach C, Skripitz R, Andreassen T, Aspenberg P. Intermittent parathyroid hormone (1-34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats. J Orthop Res 2004;22:472-478.
31. Mitsuta T, Horiuchi H, Shinoda H. Effects of topical administration of clodronate on alveolar bone resorption in rats with experimental periodontitis. J Periodontol 2002;73:479-486.
32. Goya JA, Paez HA, Mandalunis PM. Effect of topical administration of monosodium olpadronate on experimental periodontitis in rats. J Periodontol 2006;77:1-6.
33. Adachi H, Igarashi K, Mitani H, Shinoda H. Effects of topical administration of a bisphosphonate (risedronate) on orthodontic tooth movements in rats. J Dent Res 1994;73:1478-1486.
34. Igarashi K, Adachi H, Mitani H, Shinoda H. Inhibitory effect of the topical administration of a bisphosphonate (risedronate) on root resorption incident to orthodontic tooth movement in rats. J Dent Res 1996;75:1644-1649.